1 option
Remdesivir COVID-19 clinical trial / Mahesh Parmar.
- Format:
- Sound recording
- Author/Creator:
- Parmar, Mahesh K. B., Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
- Interviews on Covid-19, 2056-452X
- Language:
- English
- Subjects (All):
- Antiviral agents--Development.
- Antiviral agents.
- Clinical trials.
- Coronavirus infections--Chemotherapy.
- Coronavirus infections.
- COVID-19 (Disease)--Treatment.
- COVID-19 (Disease).
- Antiviral Agents--administration & dosage.
- Clinical Trials as Topic.
- Communicable Diseases, Emerging--drug therapy.
- Coronavirus Infections--drug therapy.
- COVID-19 Drug Treatment.
- Pneumonia, Viral--drug therapy.
- Ribonucleotides.
- SARS-CoV-2.
- Medical Subjects:
- Antiviral Agents--administration & dosage.
- Clinical Trials as Topic.
- Communicable Diseases, Emerging--drug therapy.
- Coronavirus Infections--drug therapy.
- COVID-19 Drug Treatment.
- Pneumonia, Viral--drug therapy.
- Ribonucleotides.
- SARS-CoV-2.
- Physical Description:
- 1 online resource (1 streaming audio file (12 min., 16 sec.))
- Place of Publication:
- London : Henry Stewart Talks, 2020.
- System Details:
- video file
- Contents:
- Contents: Overview of Remdesivir
- Overview of the clinical trial
- Current outcomes
- Next steps for the clinical trial
- Published preliminary report: Beigel J. H, et al. New England Journal of Medicine 2020. doi:10.1056/NEJMoa2007764.
- Notes:
- Description based on: online resource; title from information screen (HSTalks, viewed April 13, 2024).
- Audio interview.
- Title from title frames.
- Publisher Number:
- 8177 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.